EUVIMEDSkopri EUVIMED
Fallbericht

A de novo int22h‐1/int22h‐2‐flanked Xq28 deletion‐associated preferential X‐inactivation in a female with severe hemophilia B

Wan-Chun Chen, Hsiao-Jung Kao, Pui-Yan Kwok, Shyh-Shin Chiou, Yu-Ling Kuo, Wan-Yi Hsu, Ping-Tao Lu, Cian-Rong Wu, Pei-Chin Lin iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31332 ↗

At a glance

Fallbericht in Pediatric Blood & Cancer, 2024. Written by Wan-Chun Chen and 8 co-authors. Institution: School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Major MEDLINE topics: X Chromosome Inactivation, Hemophilia B. 16 references. Funded by: Kaohsiung Medical University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

A 5‐year‐old female diagnosed with severe hemophilia B began experiencing frequent muscular and joint bleeds at 19 months old. Molecular studies, including Sanger sequencing, Giemsa banding, human androgen receptor (HUMARA) assay, array‐based comparative genomic hybridization (aCGH), whole‐exome sequencing (WES), and multiplex ligation‐dependent probe amplification (MLPA), revealed a heterozygous factor IX (F9) intron 3 substitution (c.277+1G>T) inherited from her mother and a de novo heterozygous 441 kb deletion in the Xq28 region, which flanked intron 22 homologous regions 1 (int22h1) and 2 (int22h2). This rare genetic profile explains her severe phenotype and guides hereditary consultation for family planning.

Subjects

MeSH terms (MEDLINE)

X Chromosome InactivationHemophilia BHumansFemaleChild, PreschoolChromosomes, Human, XFactor IXChromosome DeletionIntrons

Author keywords

factor IX gene variantfemale hemophiliahemophiliaint22h‐1/int22h‐2‐flanked Xq28 deletionpreferential X chromosome inactivation

Substances

Factor IX

Authors and institutions

  • School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Division of Cardiovascular and Metabolic Diseases, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
  • Department of Dermatology, Cardiovascular Research Institute, and Institute for Human Genetics, University of California, San Francisco, California, USA.
  • Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID profiles: Pei-Chin Lin

Funding

  • Kaohsiung Medical University Hospital
  • Kaohsiung Medical University Chung-Ho Memorial Hospital

Cite

APA

Chen, W. C., Kao, H. J., Kwok, P. Y., Chiou, S. S., Kuo, Y. L., Hsu, W. Y., Lu, P. T., Wu, C. R., & Lin, P. C. (2024). A de novo int22h‐1/int22h‐2‐flanked Xq28 deletion‐associated preferential X‐inactivation in a female with severe hemophilia B. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31332

Vancouver

Chen WC, Kao HJ, Kwok PY, Chiou SS, Kuo YL, Hsu WY, et al. A de novo int22h‐1/int22h‐2‐flanked Xq28 deletion‐associated preferential X‐inactivation in a female with severe hemophilia B. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31332

BibTeX
@article{Chen2024,
  author = {Chen, Wan-Chun and Kao, Hsiao-Jung and Kwok, Pui-Yan and Chiou, Shyh-Shin and Kuo, Yu-Ling and Hsu, Wan-Yi and Lu, Ping-Tao and Wu, Cian-Rong and Lin, Pei-Chin},
  title = {A de novo int22h‐1/int22h‐2‐flanked Xq28 deletion‐associated preferential X‐inactivation in a female with severe hemophilia B},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31332}
}
Start for free →